Gene · 2050
Papers2,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current trends, molecular insights, and future directions toward precision medicine in the management of pediatric cerebral arteriovenous malformations. | J Neurosurg Pediatr | 2024 | 39241253 | PubTator, text mining | PubMed |
| Author Correction: Homoharringtonine suppresses tumor proliferation and migration by regulating EphB4-mediated β-catenin loss in hepatocellular carcinoma. | Cell Death Dis | 2024 | 39223114 | PubTator, text mining | PubMed |
| Correction to "SAM domain variants of EPHB4 associated with aberrant signaling are linked to lymphatic-related fetal hydrops and facial dysmorphology". | Clin Genet | 2024 | 39073083 | PubTator, text mining | PubMed |
| Identifying novel potential drug targets for endometriosis via plasma proteome screening. | Front Endocrinol (Lausanne) | 2024 | 39036049 | PubTator, text mining | PubMed |
| Osteoclast-derived coupling factors: origins and state-of-play Louis V Avioli lecture, ASBMR 2023. | J Bone Miner Res | 2024 | 38990205 | PubTator, text mining | PubMed |
| Improved efficacy of pembrolizumab combined with soluble EphB4-albumin in HPV-negative EphrinB2 positive head neck squamous cell carcinoma. | Oncotarget | 2024 | 38985143 | PubTator, text mining | PubMed |
| Deciphering the shared mechanisms of Gegen Qinlian Decoction in treating type 2 diabetes and ulcerative colitis via bioinformatics and machine learning. | Front Med (Lausanne) | 2024 | 38962743 | PubTator, text mining | PubMed |
| RETRACTION: CircRNA EPHB4 modulates stem properties and proliferation of gliomas via sponging miR-637 and up-regulating SOX10. | Mol Oncol | 2024 | 38952175 | PubTator, text mining | PubMed |
| Frontiers and future perspectives of neuroimmunology. | Fundam Res | 2024 | 38933499 | PubTator, text mining | PubMed |
| 3D bioprinting of DPSCs with GelMA hydrogel of various concentrations for bone regeneration. | Tissue Cell | 2024 | 38776731 | PubTator, text mining | PubMed |
| ED-71 Improves Bone Mass in Ovariectomized Rats by Inhibiting Osteoclastogenesis Through EphrinB2-EphB4-RANKL/OPG Axis. | Drug Des Devel Ther | 2024 | 38716369 | PubTator, text mining | PubMed |
| The Edifice of Vasculature-On-Chips: A Focused Review on the Key Elements and Assembly of Angiogenesis Models. | ACS Biomater Sci Eng | 2024 | 38712543 | PubTator, text mining | PubMed |
| Multiple receptor tyrosine kinases regulate dengue infection of hepatocytes. | Front Cell Infect Microbiol | 2024 | 38585651 | PubTator, text mining | PubMed |
| Eph-ephrin signaling couples endothelial cell sorting and arterial specification. | Nat Commun | 2024 | 38570531 | PubTator, text mining | PubMed |
| Genetic causes of lymphatic disorders: recent updates on the clinical and molecular aspects of lymphatic disease. | Curr Opin Cardiol | 2024 | 38483006 | PubTator, text mining | PubMed |
| Click chemistry in the development of PROTACs. | RSC Chem Biol | 2024 | 38456041 | PubTator, text mining | PubMed |
| Demystifying vascularized lymph node transfers and lymphatico-venous anastomoses. | Ann Transl Med | 2024 | 38304897 | PubTator, text mining | PubMed |
| Recent advances in tissue repair of the blood-brain barrier after stroke. | J Tissue Eng | 2024 | 38304736 | PubTator, text mining | PubMed |
| Review: Human stem cell-based 3D in vitro angiogenesis models for preclinical drug screening applications. | Mol Biol Rep | 2024 | 38302762 | PubTator, text mining | PubMed |
| Sialidase NEU3 Contributes to the Invasiveness of Bladder Cancer. | Biomedicines | 2024 | 38255300 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2050/papers?page=7